GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3276 - 3300 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▼ Arbitrary Fluorescence Units (AFU)
IgG Patient 1 6 moderate
G15407YE
112
IgM Patient 1 10 moderate
G15407YE
877
IgM Patient 1 22 moderate
G15407YE
887
IgM Patient 1 6 moderate
G15407YE
1020
IgA Patient 2 15 mild
G15407YE
2656
IgA Patient 2 24 mild
G15407YE
3676
IgG Patient 2 15 mild
G15407YE
3047
IgG Patient 2 24 mild
G15407YE
4074
IgM Patient 2 15 mild
G15407YE
1896
IgM Patient 2 24 mild
G15407YE
2426
IgA Patient 2 3 mild
G15407YE
4029
IgG Patient 2 3 mild
G15407YE
4477
IgM Patient 2 3 mild
G15407YE
3006
IgA Patient 3 -180 mild
G15407YE
688
IgA Patient 3 11 mild
G15407YE
1201
IgG Patient 3 -180 mild
G15407YE
246
IgG Patient 3 11 mild
G15407YE
476
IgM Patient 3 -180 mild
G15407YE
1222
IgA Patient 3 4 mild
G15407YE
1348
IgG Patient 3 4 mild
G15407YE
497
IgM Patient 3 11 mild
G15407YE
2869
IgM Patient 3 4 mild
G15407YE
3009
IgA Patient 4 12 mild
G15407YE
2731
IgG Patient 4 12 mild
G15407YE
713
IgM Patient 4 12 mild
G15407YE
8350

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024